Newsmax
@newsmaxtv·2.6M subscribers·60.1K videos
BONUS: Dr. Jen Ashton on GLP-1s and the Future of Weight-Loss Medicine | Greta Wire
Posted
June 15, 2026
Views
2,175
Likes
51
Comments
2
Engagement
2.44%
June 15, 2026
2,175
51
2
2.44%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
7:45Now PlayingCould GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound be far more than weight-loss drugs?
In this special bonus episode of Greta Wire, Greta Van Susteren is joined by Dr. Jen Ashton on NEWSMAX TV’s The Record with Greta Van Susteren to discuss a new study suggesting GLP-1 drugs may be associated with reduced cancer progression in several obesity-related cancers.
Dr. Ashton explains what the study found, what it does — and does not — prove, and why researchers are now looking at GLP-1 medications for possible effects on inflammation, the immune system, cancer spread, recurrence, and prevention. Greta also presses on the insurance question: if these drugs may help prevent expensive and devastating medical complications, why do insurers often resist paying for them upfront?
Plus, Greta asks whether the anti-inflammatory effects of GLP-1s could someday help people suffering from arthritis.
Watch this timely bonus conversation from Greta Wire and The Record with Greta Van Susteren.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
